SAN DIEGO, Sept. 21, 2026 /PRNewswire/ — CIPRA.ai, a leader in digital twin and agentic AI-driven precision and personalized chronic disease management, today announced a collaboration with Murata, a global provider of advanced electronic components and sensor technologies, to explore the development of next-generation AI-powered wearable solutions for chronic disease management.

“Our collaboration with Murata allows us to move closer to a future where patients receive more proactive, personalized care,” said Sujit Dey, Founder and President of CIPRA.ai. “By integrating advanced sensing technologies with our digital twin platform, we aim to enhance how chronic conditions are monitored and managed, enabling earlier intervention and better outcomes.”

A New Category of AI Powered Medical Wearables
The collaboration will focus on wearable technologies that enable continuous health monitoring and deliver personalized insights through AI-powered analytics. By combining real-time physiological data with CIPRA.ai’s digital twin platform, the initiative aims to advance a more proactive approach to chronic disease management, helping shift healthcare from reactive treatment to predictive, preventive care. Unlike traditional wearables, CIPRA.ai’s platform continuously adapts to each individual, helping generate insights tailored to a person’s unique health profile and evolving needs.

Advancing Value Based, Intelligence Driven Care
CIPRA.ai’s platform is built to help health systems and health plans:

• Monitor chronic patients more effectively
• Reduce avoidable hospitalizations
• Improve disease control and outcomes
• Lower total cost of care
• Accelerate adoption of value based care and improving outcomes in rural health

“By combining advanced sensing technologies with CIPRA.ai’s digital twin platform, we have an opportunity to unlock new possibilities in personalized healthcare,” said Mehul Udani, Vice President, Corporate Technology and Innovation at Murata. “We share a common vision of leveraging technology to transform sensor data into meaningful insights that can support earlier intervention, improve patient engagement, and ultimately contribute to better health outcomes.”

Setting a New Standard for Care
As healthcare continues to shift toward preventive and value-based care models, the demand for continuous, personalized monitoring solutions is growing. Through this collaboration, CIPRA.ai aims to further its mission of transforming chronic disease management through AI, digital twins, and intelligent health technologies.

“We are excited to collaborate with Murata as we continue advancing innovative solutions that support personalized, proactive care,” added Dey. “Together, we share a common vision of leveraging technology to improve the lives of patients and help healthcare organizations deliver better outcomes.”

About CIPRA.ai
CIPRA.ai is a digital health company focused on developing AI-driven platforms and services for personalized chronic disease management. By combining digital twin technology and agentic AI, CIPRA.ai generates individualized insights that support proactive care, improved health outcomes, and reduced healthcare costs. The company is committed to advancing precision health through intelligent, scalable solutions for health systems and patients. For more information, visit cipra.ai or contact info@cipra.ai. For media queries, please contact media@cipra.ai.

View original content to download multimedia:https://www.prnewswire.com/news-releases/cipraai-collaborates-with-murata-to-advance-the-future-of-ai-powered-health-wearables-302883441.html

SOURCE cipra.ai Inc